Corona Remedies IPO Subscription Status
The Corona Remedies IPO has been subscribed 137.04x times overall. Retail investors have shown interest with bids for 28.73x the shares available. The Non-Institutional Investor (NII) category has been subscribed 208.88x. Within NII, Big HNI (B-HNI) subscribed 234.02x and Small HNI (S-HNI) subscribed 158.62x. Qualified Institutional Buyers (QIBs) have subscribed 278.52x. Data last updated on 07 Apr, 04:30 PM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 08 Dec, 2025 and closes on 10 Dec, 2025. The shares are expected to list on stock exchanges on 15 Dec, 2025.
Table of Contents
Live Bidding
| Category | Offered | Applied | Amount (Cr) | Bid Details | TIMES |
|---|---|---|---|---|---|
|
QIB
|
12,88,732 | - | 38,119.37 Cr |
-
of 12,88,732
38,119.37 Cr
|
278.52x |
|
NII
|
9,66,549 | - | 21,441.47 Cr |
-
of 9,66,549
21,441.47 Cr
|
208.88x |
|
Retail
|
22,55,281 | - | 6,881.98 Cr |
-
of 22,55,281
6,881.98 Cr
|
28.73x |
|
Employee
|
61,320 | - | 95.89 Cr |
-
of 61,320
95.89 Cr
|
14.72x |
| TOTAL | 45,71,882 | - | 66,538.70 Cr |
-
66,538.70 Cr
|
137.04x |
Last Updated: 07 Apr 2026, 04:30 PM
Retail Allotment
High demand detected. The retail category is heavily oversubscribed, making the allotment a lottery where only 1 out of every 29 applicants will be successful.
Market Sentiment
Strong grey market premium of 484% suggests exceptional listing gains and high bullish sentiment among traders.
Institutional Backing
Massive institutional interest with QIBs subscribing 278.52x. This often signals long-term confidence from professional funds.
Day-wise Subscription History
Subscription trends over the last 4 days
| Date | Total | ||
|---|---|---|---|
|
21 Jan 2026
DAY 4
|
137.04x
|
||
|
QIB
278.52x
BHNI
234.02x
SHNI
158.62x
Retail
28.73x
Employee
14.72x
|
|||
|
10 Dec 2025
DAY 3
|
144.54x
|
||
|
QIB
293.80x
BHNI
-x
SHNI
-x
Retail
30.39x
|
|||
|
09 Dec 2025
DAY 2
|
9.96x
|
||
|
QIB
1.76x
BHNI
-x
SHNI
-x
Retail
6.90x
|
|||
|
08 Dec 2025
DAY 1
|
0.67x
|
||
|
QIB
0.00x
BHNI
-x
SHNI
-x
Retail
0.96x
|
|||
IPO Guru on Android
Get live GMP alerts, subscription updates, and allotment status directly on your phone. Fast, Free, and Secure.
Corona Remedies IPO Allotment Probability
Allotment probability is calculated based on current subscription multiples. Retail allotment is by lottery when oversubscribed; NII allotment is proportionate. Final numbers may change until subscription closes. This is not investment advice.
What Does This Subscription Data Mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during market hours (10 AM – 5 PM IST) on active subscription days.
Frequently Asked Questions
What is the current subscription status of Corona Remedies IPO?
As of IPO close date (10 Dec, 2025), the Corona Remedies IPO is subscribed 137.04x times. Retail category is 28.73x, and NII is 208.88x subscribed.
When is the allotment date for Corona Remedies IPO?
The allotment for Corona Remedies IPO is expected to be finalized on 11 December, 2025.
What is the GMP of Corona Remedies?
The Grey Market Premium (GMP) for Corona Remedies is currently ₹300, indicating a potential listing gain of 484%.
When will Corona Remedies IPO list on the stock market?
Corona Remedies is scheduled to list on BSE and NSE on 15 December, 2025.
What are the chances of getting allotment in Corona Remedies IPO?
The retail category is oversubscribed at 28.73x, meaning allotment is by lottery. Statistically, approximately 1 in 29 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 278.52x mean for Corona Remedies IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 278.52x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Corona Remedies IPO allotment status?
After the allotment date (11 Dec, 2025), you can check your Corona Remedies IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Corona Remedies IPO Further
Track every stage of this IPO from subscription to listing:
Discussion 0
No comments yet
Be the first to share your thoughts!